Clinical Trials Logo
  1. Home
  2. Dupuytren's Disease
  3. NCT00954746

Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859

Dupuytren's Disease Clinical Trial

Official title:
CORDLESS- Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study

Clinical Trial Summary

The purpose of study AUX-CC-860 is to assess the durability of response of the AA4500 treatment regimen. This study will also evaluate long-term safety and progression of disease in joints.

Clinical Trial Description

Phase 3 non-treatment study in which Year 2 to Year 5 year follow-up of subjects who received AA4500 in the 9-month open-label studies (AUX-CC-854 and AUX-CC-856) or the 12-month double-blind with open-label extension studies (AUX-CC-857/AUX-CC-858 and AUX-CC-859). After completion of one of the above mentioned studies, subjects are enrolled and followed once a calendar year for 4 consecutive years with at least 6 months between consecutive visits. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00954746
Study type Observational
Source Endo Pharmaceuticals
Contact
Status Completed
Phase N/A
Start date July 2009
Completion date May 2013
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05300893 - Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture N/A
Recruiting NCT04122313 - Post-contracture Release Radiation for Dupuytren's Disease
Completed NCT01498640 - Retreatment of Recurrent Dupuytren's Contractures Phase 4
Completed NCT01450397 - MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex Phase 4
Completed NCT03180957 - Repurposing Anti-TNF for Treating Dupuytren's Disease Phase 2
Completed NCT00575458 - Splinting for Dupuytren's Contracture Release N/A
Completed NCT00260429 - Collagenase in the Treatment of Dupuytrens Disease Phase 3
Recruiting NCT05067764 - Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease N/A
Completed NCT02725528 - Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's Phase 3
Completed NCT02193828 - Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules Phase 2
Active, not recruiting NCT04874870 - Effectiveness of Splinting After Collagenase Injection Phase 3
Recruiting NCT06263699 - Goniometry and Goniometric Measurement on Standardised Images in Dupuytren's Disease
Not yet recruiting NCT02294890 - Knee Stiffness in Fibrosis Diathesis N/A
Completed NCT04669704 - Effectiveness of a Tele-Rehabilitation Evidence-based Tablet App for Rehabilitation in Traumatic Bone and Soft Injuries of the Hand, Wrist and Fingers. N/A
Recruiting NCT05440240 - Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture Phase 4
Active, not recruiting NCT01446432 - Validation of Two New Questionnaires for Dupuytren's Disease N/A
Recruiting NCT06281509 - Palmaris Longus Muscle and Dupuytren N/A
Recruiting NCT06321991 - Nodular Shrinking in Dupuytren Disease Phase 2
Not yet recruiting NCT06142929 - Micronerves in Dupuytren and the Impact of Its Dissection on Recurrence
Completed NCT01567397 - Registry of Dupuytren's Contracture Treatment Outcomes N/A